Scientists increasingly find themselves working in bilateral drug development alliances. Alliances are conceptually simple, but operationally challenging, resulting in the value-eroding misalignment and delays that alliances often experience. This case study of an exemplary collaboration between a small biotech and a global biopharmaceutical company is based on 15 interviews and a lessons-learned workshop conducted with the principal alliance team members. We outline five repeatable practices identified as contributing to their success that other alliance teams can follow.

中文翻译：

---

伙伴关系应该如何为患者带来创新药物。

科学家们越来越多地发现自己在双边药物开发联盟中工作。联盟在概念上很简单，但在操作上具有挑战性，导致联盟经常经历的价值侵蚀错位和延误。本案例研究是一家小型生物技术公司与一家全球生物制药公司之间的示范合作案例，基于 15 次访谈和与主要联盟团队成员进行的经验教训研讨会。我们概述了其他联盟团队可以遵循的五个可重复的实践，这些实践被确定为有助于他们的成功。